We are live on
!
Find out more
RMDI
R.M. Davis Inc Portfolio holdings
AUM
$5.63B
1-Year Est. Return
21.26%
This Fund
S&P 500
This Quarter
Est. Return
-2.02%
1 Year Est. Return
+21.26%
3 Year Est. Return
+68.16%
5 Year Est. Return
+91.48%
10 Year Est. Return
+347.42%
AUM
$5.63B
AUM Growth
-$175M
(-3%)
Cap. Flow
+$39.4M
Cap. Flow
% of AUM
0.7%
Top 10 Holdings %
Top 10 Hldgs %
38.74%
Holding
284
New
9
Increased
99
Reduced
136
Closed
11
Top Buys
| 1 |
Broadcom
AVGO
|
+$13.6M |
| 2 |
Microsoft
MSFT
|
+$8.52M |
| 3 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$7.17M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$6.35M |
| 5 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$6.28M |
Top Sells
| 1 |
Marvell Technology
MRVL
|
+$15M |
| 2 |
Invesco BulletShares 2026 Corporate Bond ETF
BSCQ
|
+$5.84M |
| 3 |
Ecolab
ECL
|
+$4.36M |
| 4 |
Qualcomm
QCOM
|
+$3.05M |
| 5 |
Accenture
ACN
|
+$2.93M |
Sector Composition
| 1 | Technology | 23.61% |
| 2 | Financials | 10.02% |
| 3 | Industrials | 8.62% |
| 4 | Communication Services | 8.15% |
| 5 | Healthcare | 7.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
KKR & Co
KKR
$91.5B
| $342K | 0.01% |
3,700
-5
| -0.1% | -$527 |
|
227
Micron Technology
MU
$971B
| $342K | 0.01% |
1,011
-40
| -4% | -$15.7K |
|
228
Zoetis
ZTS
$32.2B
| $341K | 0.01% |
2,883
-3,785
| -57% | -$468K |
|
229
AstraZeneca
AZN
$263B
| $339K | 0.01% |
1,721
-239
| -12% | -$46.1K |
|
230
Iron Mountain
IRM
$36.9B
| $339K | 0.01% |
3,318
| – | – |
|
231
Veralto
VLTO
$23B
| $332K | 0.01% |
3,748
-379
| -9% | -$36K |
|
232
Citigroup
C
$224B
| $328K | 0.01% |
2,892
| – | – |
|
233
Enbridge
ENB
$123B
| $322K | 0.01% |
5,951
+1,495
| +34% | +$76.2K |
|
234
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
$18.3B
| $318K | 0.01% |
5,371
-1,725
| -24% | -$105K |
|
235
SAP
SAP
$182B
| $317K | 0.01% |
1,849
-29
| -2% | -$5.99K |
|
236
TSMC
TSM
$2.14T
| $310K | 0.01% |
916
-85
| -8% | -$29.3K |
|
237
Energy Transfer Partners
ET
$69.5B
| $307K | 0.01% |
+15,928
| New | +$292K |
|
238
Gilead Sciences
GILD
$166B
| $303K | 0.01% |
2,174
+450
| +26% | +$63K |
|
|
HOLX
239
DELISTED
Hologic
HOLX
| $302K | 0.01% |
3,995
-420
| -10% | -$31.6K |
|
240
iShares S&P GSCI Commodity-Indexed Trust
GSG
$965M
| $295K | 0.01% |
9,150
| – | – |
|
241
iShares Russell 2000 Growth ETF
IWO
$14.9B
| $292K | 0.01% |
930
+284
| +44% | +$94.5K |
|
242
iShares Core Dividend Growth ETF
DGRO
$42.3B
| $289K | 0.01% |
4,120
-143
| -3% | -$10.3K |
|
243
EOG Resources
EOG
$74.1B
| $288K | 0.01% |
+1,993
| New | +$242K |
|
244
Vanguard Real Estate ETF
VNQ
$39.5B
| $277K | ﹤0.01% |
3,120
+115
| +4% | +$10.5K |
|
245
American Express
AXP
$248B
| $276K | ﹤0.01% |
911
-482
| -35% | -$162K |
|
246
iShares ESG Aware MSCI USA ETF
ESGU
$18B
| $268K | ﹤0.01% |
+1,894
| New | +$280K |
|
247
Novartis
NVS
$290B
| $267K | ﹤0.01% |
+1,747
| New | +$268K |
|
248
Vulcan Materials
VMC
$38B
| $265K | ﹤0.01% |
975
| – | – |
|
249
Quest Diagnostics
DGX
$22.8B
| $264K | ﹤0.01% |
+1,347
| New | +$262K |
|
250
Bristol-Myers Squibb
BMY
$123B
| $257K | ﹤0.01% |
+4,245
| New | +$247K |
|
Similar funds
F
RCMU
DCP
TSW
CRC
DWM
AIM
O